Liling Mei
Impact in
- Pharmaceutical Science top 2%
- Advanced Drug Delivery Systems
- Advancements in Transdermal Drug Delivery
- Drug Solubulity and Delivery Systems
- Molecular Medicine top 10%
Papers in
-
- Advanced Drug Delivery Systems 5
- Drug Solubulity and Delivery Systems 2
-
- Nanoparticle-Based Drug Delivery 2
- Co-authors
- Chuanbin Wu (14 shared papers)Xin Pan (14 shared papers)Ying Huang (11 shared papers)Jintian Chen (8 shared papers)Di Huang (2 shared papers)Tingting Peng (5 shared papers)Ge Li (1 shared paper)Pin Dong (1 shared paper)
- Journals
- Drug Delivery (2 papers)Colloids and Surfaces B Biointerfaces (2 papers)Biomaterials Science (2 papers)Asian Journal of Pharmaceutical Sciences (1 paper)Journal of Materials Chemistry B (1 paper)
- Partner nations
- ChinaUnited KingdomCanada
In The Last Decade
Liling Mei
14 papers receiving 457 citations
Peers
Comparison fields: 5 of 82
- Pharmaceutical Science 196
- Molecular Medicine 44
- Biomaterials 106
- Periodontics 32
- Rehabilitation 33
Countries citing papers authored by Liling Mei
This map shows the geographic impact of Liling Mei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liling Mei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liling Mei more than expected).
Fields of papers citing papers by Liling Mei
This network shows the impact of papers produced by Liling Mei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liling Mei. The network helps show where Liling Mei may publish in the future.
Co-authors
The 25 scholars most cited alongside Liling Mei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 103 | |
| 2 | 2017 | 53 | |
| 3 | 2017 | 48 | |
| 4 | 2020 | 36 | |
| 5 | 2015 | 34 | |
| 6 | 2017 | 32 | |
| 7 | 2015 | 28 | |
| 8 | 2018 | 26 | |
| 9 | 2015 | 23 | |
| 10 | 2017 | 18 | |
| 11 | 2021 | 17 | |
| 12 | 2017 | 17 | |
| 13 | 2021 | 17 | |
| 14 | 2014 | 13 |
About Liling Mei
Liling Mei is a scholar working on Pharmaceutical Science, Biomaterials, Cell Biology, Molecular Biology and Rheumatology, having authored 14 papers that have together received 465 indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (5 papers), Proteoglycans and glycosaminoglycans research (3 papers), Drug Solubulity and Delivery Systems (2 papers), Osteoarthritis Treatment and Mechanisms (2 papers), Nanoparticle-Based Drug Delivery (2 papers), Ocular Surface and Contact Lens (2 papers), Liquid Crystal Research Advancements (2 papers) and Bioactive Natural Diterpenoids Research (1 paper). The work is most often cited by research in Pharmaceutical Science (196 citations), Molecular Medicine (44 citations), Biomaterials (106 citations), Periodontics (32 citations) and Rehabilitation (33 citations). Liling Mei has collaborated with scholars based in China, United Kingdom and Canada. Frequent co-authors include Chuanbin Wu, Xin Pan, Ying Huang, Jintian Chen, Di Huang, Tingting Peng, Ge Li, Pin Dong, Yixuan Dong and Zhouhua Wang. Their work appears in journals such as Drug Delivery, Colloids and Surfaces B Biointerfaces, Biomaterials Science, Asian Journal of Pharmaceutical Sciences and Journal of Materials Chemistry B.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.